5 Reasons PD-L1 Inhibitors Are Changing Cancer Treatment

σε πρόσθεσε στο Lançamentos & Anúncios

2026-10-06 05:15:36 -

PD-L1 inhibitors have become a cornerstone of modern oncology. They are not just another drug class — they represent a fundamentally different approach to treating cancer. Here are five reasons they are changing the field. First, they harness the immune system, offering a targeted approach that differs from chemotherapy. Second, they produce durable responses in some patients, with...

0 Σχόλια 0 Μοιράστηκε 0 Προεπισκόπηση